WNT5A is induced by inflammatory mediators in bone marrow stromal cells and regulates cytokine and chemokine production

Journal of Bone and Mineral Research

Volumn 27, Issue 3, 2012, Pages 575-585

  Rauner, Martina ^a   Stein, Nicola ^a   Winzer, Maria ^a   Goettsch, Claudia ^a   Zwerina, Jochen ^b,c   Schett, Georg ^b   Distler, Jörg H W ^b   Albers, Joachim ^d   Schulze, Jochen ^d   Schinke, Thorsten ^d   Bornhäuser, Martin ^a   Platzbecker, Uwe ^a   Hofbauer, Lorenz C ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c HANUSCH HOSPITAL   (Austria)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

BONE MARROW STROMAL CELL; CHEMOKINE; CYTOKINE; INFLAMMATION; WNT5A

Indexed keywords

CHEMOKINE; CXCL1 CHEMOKINE; CYTOKINE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN KINASE B; RANTES; TUMOR NECROSIS FACTOR ALPHA; WNT5A PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; MICROARRAY ANALYSIS; MONOCYTE; MOUSE; NONHUMAN; OSTEOBLAST; PATHOGENESIS; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; STROMA CELL; SUPERNATANT; SYNOVIUM; T LYMPHOCYTE; TRANSGENIC MOUSE;

ADULT; ANIMALS; ARTHRITIS, RHEUMATOID; BONE MARROW CELLS; CELL MOVEMENT; CELL SEPARATION; CELLS, CULTURED; CHEMOKINES; CYTOKINES; FEMALE; HUMANS; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; PROTO-ONCOGENE PROTEINS; STROMAL CELLS; TUMOR NECROSIS FACTOR-ALPHA; WNT PROTEINS;

EID: 84857270110     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.1488     Document Type: Article

References (34)

1. McInnes IB, Schett G., Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol. 2007; 7 (6): 429-42.
2. Firestein GS., Evolving concepts of rheumatoid arthritis. Nature. 2003; 423 (6937): 356-61.
3. Lefevre S, Knedla A, Tennie C, Kampmann A, Wunrau C, Dinser R, et al. Synovial fibroblasts spread rheumatoid arthritis to unaffected joints. Nat Med. 2009; 15 (12): 1414-20.
4. Johnson ML, Harnish K, Nusse R, Van Hul W., LRP5 and Wnt signaling: a union made for bone. J Bone Miner Res. 2004; 19 (11): 1749-57.
5. Petersen CP, Reddien PW., Wnt signaling and the polarity of the primary body axis. Cell. 2009; 139 (6): 1056-68.
6. Reya T, Clevers H., Wnt signalling in stem cells and cancer. Nature. 2005; 434 (7035): 843-50.
7. Slusarski DC, Pelegri F., Calcium signaling in vertebrate embryonic patterning and morphogenesis. Dev Biol. 2007; 307 (1): 1-13.
8. Diarra D, Stolina M, Polzer K, Zwerina J, Ominsky MS, Dwyer D, et al. Dickkopf-1 is a master regulator of joint remodeling. Nat Med. 2007; 13 (2): 156-63.
9. Walsh NC, Reinwald S, Manning CA, Condon KW, Iwata K, Burr DB, et al. Osteoblast function is compromised at sites of focal bone erosion in inflammatory arthritis. J Bone Miner Res. 2009; 24 (9): 1572-85.
10. Blumenthal A, Ehlers S, Lauber J, Buer J, Lange C, Goldmann T, et al. The Wingless homolog WNT5A and its receptor Frizzled-5 regulate inflammatory responses of human mononuclear cells induced by microbial stimulation. Blood. 2006; 108 (3): 965-73.
11. Pereira C, Schaer DJ, Bachli EB, Kurrer MO, Schoedon G., Wnt5A/CaMKII signaling contributes to the inflammatory response of macrophages and is a target for the antiinflammatory action of activated protein C and interleukin-10. Arterioscler Thromb Vasc Biol. 2008; 28 (3): 504-10.
12. Sen M, Chamorro M, Reifert J, Corr M, Carson DA., Blockade of Wnt-5A/frizzled 5 signaling inhibits rheumatoid synoviocyte activation. Arthritis Rheum. 2001; 44 (4): 772-81.
13. Sen M, Lauterbach K, El-Gabalawy H, Firestein GS, Corr M, Carson DA., Expression and function of wingless and frizzled homologs in rheumatoid arthritis. Proc Natl Acad Sci USA. 2000; 97 (6): 2791-6.
14. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988; 31 (3): 315-24.
15. van Gestel AM, Prevoo ML, van't Hof MA, van Rijswijk MH, van de Putte LB, van Riel PL., Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria. Arthritis Rheum. 1996; 39 (1): 34-40.
16. Keffer J, Probert L, Cazlaris H, Georgopoulos S, Kaslaris E, Kioussis D, et al. Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. Embo J. 1991; 10 (13): 4025-31.
17. Rauner M, Goettsch C, Stein N, Thiele S, Bornhaeuser M, De Bosscher K, et al. Dissociation of osteogenic and immunological effects by the selective glucocorticoid receptor agonist, compound A, in human bone marrow stromal cells. Endocrinology. 2011; 152 (1): 103-12.
18. Schmidt K, Schinke T, Haberland M, Priemel M, Schilling AF, Mueldner C, et al. The high mobility group transcription factor Sox8 is a negative regulator of osteoblast differentiation. J Cell Biol. 2005; 168 (6): 899-910.
19. Rauner M, Sipos W, Goettsch C, Wutzl A, Foisner R, Pietschmann P, et al. Inhibition of lamin A/C attenuates osteoblast differentiation and enhances RANKL-dependent osteoclastogenesis. J Bone Miner Res. 2009; 24 (1): 78-86.
20. Albers J, Schulze J, Gebauer M, Baranowsky A, Keller J, Beil TF, et al. Control of bone formation by the serpentine receptor Frizzled-9. J Cell Biol. 2011; 192 (6): 1057-72.
21. Almeida M, Han L, Bellido T, Manolagas SC, Kousteni S., Wnt proteins prevent apoptosis of both uncommitted osteoblast progenitors and differentiated osteoblasts by beta-catenin-dependent and -independent signaling cascades involving Src/ERK and phosphatidylinositol 3-kinase/AKT. J Biol Chem. 2005; 280 (50): 41342-51.
22. Kawasaki A, Torii K, Yamashita Y, Nishizawa K, Kanekura K, Katada M, et al. Wnt5a promotes adhesion of human dermal fibroblasts by triggering a phosphatidylinositol-3 kinase/Akt signal. Cell Signal. 2007; 19 (12): 2498-506.
23. Liu G, Bafico A, Aaronson SA., The mechanism of endogenous receptor activation functionally distinguishes prototype canonical and noncanonical Wnts. Mol Cell Biol. 2005; 25 (9): 3475-82.
24. Kim J, Kim J, Kim DW, Ha Y, Ihm MH, Kim H, et al. Wnt5a induces endothelial inflammation via beta-catenin-independent signaling. J Immunol. 2006; 185 (2): 1274-82.
25. Enomoto M, Hayakawa S, Itsukushima S, Ren DY, Matsuo M, Tamada K, et al. Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signaling. Oncogene. 2009; 28 (36): 3197-208.
26. McDonald SL, Silver A., The opposing roles of Wnt-5a in cancer. Br J Cancer. 2009; 101 (2): 209-14.
27. Peng L, Dong G, Xu P, Ren LB, Wang CL, Aragon M, et al. Expression of Wnt5a in tooth germs and the related signal transduction analysis. Arch Oral Biol. 2010; 55 (2): 108-14.
28. Le Goff B, Blanchard F, Berthelot JM, Heymann D, Maugars Y., Role for interleukin-6 in structural joint damage and systemic bone loss in rheumatoid arthritis. Joint Bone Spine. 2010; 77 (3): 201-5.
29. Nishimoto N, Kishimoto T., Interleukin 6: from bench to bedside. Nat Clin Pract Rheumatol. 2006; 2 (11): 619-26.
30. Ferraccioli G, Bracci-Laudiero L, Alivernini S, Gremese E, Tolusso B, De Benedetti F., Interleukin-1β and interleukin-6 in arthritis animal models: roles in the early phase of transition from acute to chronic inflammation and relevance for human rheumatoid arthritis. Mol Med. 2010; 16 (11-12): 552-7.
31. Gabay C, Lamacchia C, Palmer G., IL-1 pathways in inflammation and human diseases. Nat Rev Rheumatol. 2010; 6 (4): 232-41.
32. Axmann R, Bohm C, Kronke G, Zwerina J, Smolen J, Schett G., Inhibition of interleukin-6 receptor directly blocks osteoclast formation in vitro and in vivo. Arthritis Rheum. 2009; 60 (9): 2747-56.
33. Zwerina J, Redlich K, Polzer K, Joosten L, Kronke G, Distler J, et al. TNF-induced structural joint damage is mediated by IL-1. Proc Natl Acad Sci USA. 2007; 104 (28): 11742-7.
34. Ghosh MC, Collins GD, Vandanmagsar B, Patel K, Brill M, Carter A, et al. Activation of Wnt5A signaling is required for CXC chemokine ligand 12-mediated T-cell migration. Blood. 2009; 114 (7): 1366-73.